We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

ThromboGenics Appoints Dr David Guyer to its Board of Directors

News   Dec 23, 2013

 
ThromboGenics Appoints Dr David Guyer to its Board of Directors
 
 
 

RELATED ARTICLES

New Method to Synthesize and Screen Macrocyclic Compounds

News

Scientists at EPFL have found a way to generate libraries of more than 9,000 of macrocyclic molecules below 1 KDa, all with high structural diversity.

READ MORE

Pomegranate Juice During Pregnancy May Improve Brain Development

News

Clinical researchers are exploring whether pomegranate juice intake during pregnancy can have a protective effect. Now, researchers present their preliminary findings from a clinical trial of expectant mothers whose babies were diagnosed with intrauterine growth restriction (IUGR).

READ MORE

Team Design Drug Molecule to Improve Heart Attack Recovery

News

A new molecule has been developed that could help preserve heart tissue during – and even after – a heart attack.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE